Pitfalls of using the risk ratio in meta-analysis

被引:43
|
作者
Bakbergenuly, Ilyas [1 ]
Hoaglin, David C. [2 ]
Kulinskaya, Elena [1 ]
机构
[1] Univ East Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
关键词
beta-binomial model; log-binomial model; relative risk; response ratio; risk difference; BINARY OUTCOMES METHODS; RELATIVE RISK; CLINICAL-TRIALS; ABSOLUTE RISK; BINOMIAL MODEL; HETEROGENEITY; VARIANCE; BIAS; DIFFERENCE; REGRESSION;
D O I
10.1002/jrsm.1347
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
For meta-analysis of studies that report outcomes as binomial proportions, the most popular measure of effect is the odds ratio (OR), usually analyzed as log(OR). Many meta-analyses use the risk ratio (RR) and its logarithm because of its simpler interpretation. Although log(OR) and log(RR) are both unbounded, use of log(RR) must ensure that estimates are compatible with study-level event rates in the interval (0, 1). These complications pose a particular challenge for random-effects models, both in applications and in generating data for simulations. As background, we review the conventional random-effects model and then binomial generalized linear mixed models (GLMMs) with the logit link function, which do not have these complications. We then focus on log-binomial models and explore implications of using them; theoretical calculations and simulation show evidence of biases. The main competitors to the binomial GLMMs use the beta-binomial (BB) distribution, either in BB regression or by maximizing a BB likelihood; a simulation produces mixed results. Two examples and an examination of Cochrane meta-analyses that used RR suggest bias in the results from the conventional inverse-variance-weighted approach. Finally, we comment on other measures of effect that have range restrictions, including risk difference, and outline further research.
引用
收藏
页码:398 / 419
页数:22
相关论文
共 50 条
  • [1] Pitfalls in meta-analysis
    Palmowski, Andriko
    Nielsen, Sabrina M.
    INFLAMMOPHARMACOLOGY, 2020, 28 (02) : 617 - 618
  • [2] Pitfalls in meta-analysis
    Andriko Palmowski
    Sabrina M. Nielsen
    Inflammopharmacology, 2020, 28 : 617 - 618
  • [3] Using risk difference as opposed to odds-ratio in meta-analysis
    Messori, Andrea
    Maratea, Dario
    Fadda, Valeria
    Trippoli, Sabrina
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 164 (01) : 127 - 127
  • [4] Meta-analysis: pitfalls and hints
    Greco, T.
    Zangrillo, A.
    Biondi-Zoccai, G.
    Landoni, G.
    HEART LUNG AND VESSELS, 2013, 5 (04) : 219 - 225
  • [5] Potentials and pitfalls of meta-analysis on statins
    Lotrionte, Marzia
    Agostoni, Pierfrancesco
    Biondi-Zoccai, Giuseppe G. L.
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (01): : E3 - E3
  • [6] Meta-analysis of clinical trials: uses and pitfalls
    Boissel, Jean-Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (4-5): : 759 - 770
  • [7] Potentials and pitfalls of meta-analysis on statins - Reply
    Coleman, Craig I.
    White, C. Michael
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (01): : E5 - E5
  • [8] Drug Safety Meta-Analysis: Promises and Pitfalls
    Michael A. Stoto
    Drug Safety, 2015, 38 : 233 - 243
  • [9] Drug Safety Meta-Analysis: Promises and Pitfalls
    Stoto, Michael A.
    DRUG SAFETY, 2015, 38 (03) : 233 - 243
  • [10] Systematic review and meta-analysis: pitfalls of methods
    Lukina, Yu. V.
    Martsevich, S. Yu.
    Kutishenko, N. P.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (02) : 180 - 185